TherapeuticsMD (TXMD) Change in Cash (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Change in Cash came in at $936000.0 in Q1 2026, up 36.44% YoY from $686000.0 in Q1 2025, and up 154.35% on a QoQ basis from $368000.0 in Q4 2025.
TherapeuticsMD (TXMD) Change in Cash (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Change in Cash data on file, last reported at $936000.0 in Q1 2026.
- Quarterly Change in Cash rose 36.44% year-over-year to $936000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 90.05% YoY) and the FY2025 annual result came in at $2.4 million, up 231.15% from the prior year.
- Change in Cash climbed to $936000.0 in Q1 2026, from $368000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $12.0 million in Q3 2022 to a low of -$34.7 million in Q1 2022.
- A 5-year average of -$3.3 million and a median of $12000.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash plunged 160.8% — and 2025, when it jumped 6136.36%.
- Tracing TXMD's Change in Cash over 5 years: stood at $11.0 million in 2022, then plunged by 153.14% to -$5.8 million in 2023, then soared by 100.21% to $12000.0 in 2024, then soared by 2966.67% to $368000.0 in 2025, then surged by 154.35% to $936000.0 in 2026.
- The last three Change in Cash figures came in at $936000.0 (Q1 2026), $368000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 770,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 770,000.00 |
| Mar 31, 2026 | 936,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 324,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -185,000.00 |
| Jun 30, 2024 | 894,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | -5.84 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | -3.52 Mn |
| Mar 31, 2023 | -32.07 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 12.03 Mn |
| Jun 30, 2022 | -4.08 Mn |
| Mar 31, 2022 | -34.74 Mn |
| Dec 31, 2021 | -39.72 Mn |
| Sep 30, 2021 | -6.58 Mn |